Cocrystal Pharma Inc (COCP) stock has gained 236.00% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives COCP stock a score of 69 out of a possible 100.
That rank is chiefly influenced by a fundamental score of 90. In addition to the average rating from Wall Street analysts, COCP stock has a mean target price of 4.75. This means analysts expect the stock to climb 182.74% over the next 12 months. COCP's rank also includes a short-term technical score of 85. The long-term technical score for COCP is 33.
What's Happening with COCP Stock Today
Cocrystal Pharma Inc (COCP) stock is up 1.88% while the S&P 500 has gained 0.1% as of 11:58 AM on Wednesday, Dec 2. COCP has gained $0.03 from the previous closing price of $1.65 on volume of 3,865,002 shares. Over the past year the S&P 500 has risen 18.52% while COCP has gained 236.00%. COCP lost -$1.58 per share in the over the last 12 months.